4D Molecular Therapeutics (FDMT) Cash flow

515 Followers

4D Molecular Therapeutics Cash Flow

FDMT's free cash flow for Q4 2025 was $27.92M. For the 2025 fiscal year, FDMT's free cash flow was decreased by $29.29M and operating cash flow was $28.55M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -109.08M	$ -134.59M	$ -75.79M	$ -86.69M	$ -69.13M
Investing Cash Flow	$ -92.97M	$ -302.44M	$ 115.72M	$ -17.05M	$ -172.68M
Financing Cash Flow	$ 112.96M	$ 337.25M	$ 156.83M	$ 3.08M	$ 118.09M
End Cash Position	$ 60.24M	$ 149.34M	$ 249.11M	$ 52.35M	$ 153.00M
Free Cash Flow	$ -109.08M	$ -138.37M	$ -78.56M	$ -98.22M	$ -78.24M

Currency in USD